Along with the “crypto crackdown” by financial regulators in the wake of huge cryptocurrency losses and bankruptcies, Congress is discussing crypto legislation.
The House Financial Services Committee has a new Subcommittee on Digital Assets, Financial Technology and Inclusion chaired by Congressman French Hill (R-AR). Chairman Hill will join us for a keynote presentation, followed by an expert panel discussion. Among other questions, the webinar will consider: Will there be crypto legislation? What might it and what should it provide or not provide? What will be the most contentious issues? What related oversight should Congress provide?
Featured panelists:
- The Honorable J. French Hill, U.S. Congressman (AR-02) and Chairman, Digital Assets, Financial Technology and Inclusion Subcommittee of the House Committee on Financial Services
- Dina Ellis Rochkind, Counsel, Government Affairs and Strategy, Paul Hastings
- Alexandra Harrison Gaiser, Director of Regulatory Affairs, River Financial
- Patrick McCarty, President, McCarty Financial, LLC and Adjunct Professor of Law, Georgetown Law
- Patrick Daugherty, Partner, Foley & Lardner LLP and Adjunct Professor, Cornell Law School
- [Moderator] J.C. Boggs, Partner, Government Advocacy and Public Policy, King & Spalding
To learn more and register to attend, please click here.
People
Related Insights
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…
July 16, 2025
Health Care Law Today Podcast
Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance
In this episode, Monica Chmielewski, vice chair of Foley’s Health Care Practice Group and Shannon Sumner, Chief Compliance Officer and Nashville’s Office Managing Principal of PYA explore how supply chain compliance is affecting the health care industry and share the risks and penalties associated with not being in compliance.
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…